 |
Oxford Finance Corporation has established a Scientific Advisory Board to provide guidance on the science surrounding the ongoing due diligence and evaluations for Oxford’s loans and investments. Representing a broad range of disciplines within the medical community, the board shares industry trends and insights about market sectors pertinent to Oxford’s portfolio companies and potential clients.
The Scientific Advisory Board is comprised of the following highly-credentialed physicians active in medicine, science, business and academia:
T. Forcht Dagi, M.D., MPH, MBA, FACS, FCCM
Scientific Advisory Board Chairman
The Harvard-MIT Division of Health Sciences and Technology
Neurosurgery and Critical Care
Richard J. Cohen, M.D., Ph.D
The Whitaker Professor
The Harvard-MIT Division of Health Sciences and Technology
Cardiology and Medical Devices
Elkan Gamzu, Ph.D
enERGetics Biopharmaceutical Consultancy, LLC
Neuropharmacology and Drug Development
|
| |
Steven F. Isenberg, M.D.
Indiana University School of Medicine
Department of Otolaryngology Head and Neck Surgery
Otolaryngology, Allergy, Clinical Informatics, Outcomes, Medical and
Surgical Services and Medical Practice Management
Igor J. Koralnik, M.D.
Associate Professor of Neurology
The Beth Israel Deaconess Medical Center and Harvard Medical School
Neurology and Virology
T. Clive Lee, M.D., Ph.D, FRCSI, FRCSEd, CEng, MIEI
Professor of Anatomy
Royal College of Surgeons in Ireland, Dublin
Tissue Engineering and Materials
Margaret K. Offermann, M.D., Ph.D
Professor of Hematology and Oncology and Professor of Medicine
The Winship Cancer Institute, Emory University School of Medicine
Oncology, Endothelial Biology and Tumor Virology
Michele Trucksis, M.D., Ph.D
Clinical Associate in Medicine
The Massachusetts General Hospital and Harvard Medical School
Infectious Diseases
|
